Found: 191
Select item for more details and to access through your institution.
A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 807, doi. 10.1111/dom.13960
- By:
- Publication type:
- Article
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/790635
- By:
- Publication type:
- Article
Additional hepatic <sup>166</sup>Ho-radioembolization in patients with neuroendocrine tumours treated with <sup>177</sup>Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Frequent Genetic Changes in Childhood Pheochromocytomas.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1073, n. 1, p. 166, doi. 10.1196/annals.1353.017
- By:
- Publication type:
- Article
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview.
- Published in:
- Pituitary, 2023, v. 26, n. 4, p. 333, doi. 10.1007/s11102-023-01325-4
- By:
- Publication type:
- Article
Acromegalic gigantism, physicians and body snatching. Past or present?
- Published in:
- Pituitary, 2012, v. 15, n. 3, p. 312, doi. 10.1007/s11102-012-0389-5
- By:
- Publication type:
- Article
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients.
- Published in:
- Pituitary, 2011, v. 14, n. 3, p. 253, doi. 10.1007/s11102-010-0289-5
- By:
- Publication type:
- Article
Acromegaly and gigantism in the medical literature. Case descriptions in the era before and the early years after the initial publication of Pierre Marie (1886).
- Published in:
- Pituitary, 2009, v. 12, n. 3, p. 236, doi. 10.1007/s11102-008-0138-y
- By:
- Publication type:
- Article
Somatostatin receptor imaging for neuroendocrine tumors.
- Published in:
- Pituitary, 2006, v. 9, n. 3, p. 243, doi. 10.1007/s11102-006-0270-5
- By:
- Publication type:
- Article
New Medical Treatment for Acromegaly.
- Published in:
- Pituitary, 1999, v. 2, n. 1, p. 89, doi. 10.1023/A:1009930223314
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
Salvage Therapy with <sup>177</sup>Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 383, doi. 10.2967/jnumed.109.068957
- By:
- Publication type:
- Article
Effects of Therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³]Octreotate in Patients with Paraganglioma, Meningioma, Small Cell Lung Carcinoma, and Melanoma.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1599
- By:
- Publication type:
- Article
Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 76S
- By:
- Publication type:
- Article
The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.
- Published in:
- Endocrine Pathology, 2023, v. 34, n. 4, p. 437, doi. 10.1007/s12022-023-09768-y
- By:
- Publication type:
- Article
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
- Published in:
- Endocrine Pathology, 2022, v. 33, n. 1, p. 115, doi. 10.1007/s12022-022-09708-2
- By:
- Publication type:
- Article
Recent Developments in Drug Therapy for Cushing's Disease.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Medical Therapy of Acromegaly: Efficacy and Safety of Somatostatin Analogues.
- Published in:
- Drugs, 2009, v. 69, n. 16, p. 2207, doi. 10.2165/11318510-000000000-00000
- By:
- Publication type:
- Article
Editorial: Early Genetic and Clinical Diagnosis in MEN1.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13639
- By:
- Publication type:
- Article
Risk Factors for Meningitis After Transsphenoidal Surgery.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. 4, p. 852
- By:
- Publication type:
- Article
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4675, doi. 10.1007/s12325-023-02627-6
- By:
- Publication type:
- Article
Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 1, p. K1, doi. 10.1093/ejendo/lvae075
- By:
- Publication type:
- Article
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 3, p. 399, doi. 10.1530/EJE-22-0339
- By:
- Publication type:
- Article
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using <sup>177</sup>Lu-DOTATATE.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 1, p. 45, doi. 10.1530/EJE-18-0901
- By:
- Publication type:
- Article
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
- Published in:
- European Journal of Endocrinology, 2016, v. 175, n. 5, p. 361, doi. 10.1530/EJE-16-0392
- By:
- Publication type:
- Article
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 4, p. 337, doi. 10.1530/EJE-14-0897
- By:
- Publication type:
- Article
Radionuclide therapy in neuroendocrine tumors.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 1, p. R1, doi. 10.1530/EJE-14-0488
- By:
- Publication type:
- Article
Functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs).
- Published in:
- European Journal of Endocrinology, 2014, v. 170, n. 5, p. R173, doi. 10.1530/EJE-14-0077
- By:
- Publication type:
- Article
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 1, p. 51, doi. 10.1530/EJE-13-0093
- By:
- Publication type:
- Article
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2013, v. 167, n. 1, p. 67, doi. 10.1530/EJE-12-0594
- By:
- Publication type:
- Article
Serum inhibin pro-&agr;C is a tumor marker for adrenocortical carcinomas.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 2, p. 281, doi. 10.1530/EJE-11-0693
- By:
- Publication type:
- Article
Diagnostic imaging of dopamine receptors in pituitary adenomas.
- Published in:
- European Journal of Endocrinology, 2007, v. 156, n. S1, p. S53, doi. 10.1530/eje.1.02349
- By:
- Publication type:
- Article
Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?
- Published in:
- European Journal of Endocrinology, 2006, v. 155, n. 5, p. 717, doi. 10.1530/eje.1.02281
- By:
- Publication type:
- Article
Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly.
- Published in:
- European Journal of Endocrinology, 2005, v. 153, n. 1, p. 67, doi. 10.1530/eje.1.01935
- By:
- Publication type:
- Article
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 4, p. 645, doi. 10.1530/eje.1.01876
- By:
- Publication type:
- Article
The bio-assay quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 2, p. 217, doi. 10.1530/eje.1.01838
- By:
- Publication type:
- Article
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
- Published in:
- Journal of Surgical Oncology, 2019, v. 120, n. 6, p. 966, doi. 10.1002/jso.25667
- By:
- Publication type:
- Article
Effect of epigenetic treatment on SST<sub>2</sub> expression in neuroendocrine tumour patients.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.957
- By:
- Publication type:
- Article
Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.
- Published in:
- European Journal of Clinical Investigation, 2017, v. 47, n. 4, p. 289, doi. 10.1111/eci.12728
- By:
- Publication type:
- Article
Leucocyte-bound apolipoprotein B in the circulation is inversely associated with the presence of clinical and subclinical atherosclerosis.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 8, p. 690, doi. 10.1111/eci.12650
- By:
- Publication type:
- Article
Toni Mochty: Bardet Biedl syndrome "avant la lettre".
- Published in:
- Clinical Genetics, 2020, v. 97, n. 3, p. 536, doi. 10.1111/cge.13647
- By:
- Publication type:
- Article
Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 40, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with <sup>177</sup>LuDOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article